Vertex Pharmaceuticals (VRTX) Change in Taxes (2011 - 2012)
Vertex Pharmaceuticals' quarterly Change in Taxes came in at -$3.2 million in Q4 2012, down 236.03% year-on-year from $2.3 million in Q1 2012, and down 185.99% quarter-over-quarter from $3.7 million in Q3 2012.
Vertex Pharmaceuticals has reported Change in Taxes for 2 years, with the latest figure at -$3.2 million in Q4 2012.
- For the quarter ending Q4 2012, Change in Taxes fell 236.03% year-over-year to -$3.2 million; the trailing twelve-month figure through Dec 2012 stood at -$11.4 million (changed N/A YoY), and the FY2012 full-year result was -$11.4 million, down 194.08% from the prior year.
- Change in Taxes for Q4 2012 stood at -$3.2 million, down from $3.7 million in the prior quarter.
- The five-year high for Change in Taxes was $3.7 million in Q3 2012, with the low at -$11.9 million in Q1 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | -3.16 Mn |
| Dec 31, 2012 | -3.16 Mn |
| Sep 30, 2012 | 3.67 Mn |
| Sep 30, 2012 | 3.67 Mn |
| Mar 31, 2012 | -11.87 Mn |
| Mar 31, 2012 | -11.87 Mn |
| Dec 31, 2011 | 2.32 Mn |
| Dec 31, 2011 | 2.32 Mn |
| Sep 30, 2011 | -5.46 Mn |
| Sep 30, 2011 | -5.46 Mn |